| Autor: |
Yilmaz Mahmut, Maass Dorothea, Tiwari Neha, Waldmeier Lorenz, Schmidt Petra, Lehembre François, Christofori Gerhard |
| Rok vydání: |
2011 |
| Zdroj: |
The EMBO journal |
| DOI: |
10.1038/emboj.2011.319 |
| Popis: |
Acquiring resistance against transforming growth factor ß (TGFß) induced growth inhibition at early stages of carcinogenesis and shifting to TGFß's tumour promoting functions at later stages is a pre requisite for malignant tumour progression and metastasis. We have identified the transcription factor distal less homeobox 2 (Dlx2) to exert critical functions during this switch. Dlx2 counteracts TGFß induced cell cycle arrest and apoptosis in mammary epithelial cells by at least two molecular mechanisms: Dlx2 acts as a direct transcriptional repressor of TGFß receptor II (TGFßRII) gene expression and reduces canonical Smad dependent TGFß signalling and expression of the cell cycle inhibitor p21(CIP1) and increases expression of the mitogenic transcription factor c Myc. On the other hand Dlx2 directly induces the expression of the epidermal growth factor (EGF) family member betacellulin which promotes cell survival by stimulating EGF receptor signalling. Finally Dlx2 expression supports experimental tumour growth and metastasis of B16 melanoma cells and correlates with tumour malignancy in a variety of human cancer types. These results establish Dlx2 as one critical player in shifting TGFß from its tumour suppressive to its tumour promoting functions. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
